GENEMAY INC. Trademark

Trademark Overview

On Tuesday, May 7, 2002, a trademark application was filed for GENEMAY INC. with the United States Patent and Trademark Office. The USPTO has given the GENEMAY INC. trademark a serial number of 78126827. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Sunday, March 30, 2003. This trademark is owned by GeneMay Inc.. The GENEMAY INC. trademark is filed in the Advertising, Business and Retail Services category with the following description:

The manufacture and sale of non-hazardous, non-infectious composite biological reagents, and chemicals for scientific research.
genemay inc.

General Information

Serial Number78126827
Word MarkGENEMAY INC.
Filing DateTuesday, May 7, 2002
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateSunday, March 30, 2003
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesThe manufacture and sale of non-hazardous, non-infectious composite biological reagents, and chemicals for scientific research.
Pseudo MarkGENE MAY INC

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, May 15, 2002
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGeneMay Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92126

Trademark Events

Event DateEvent Description
Sunday, March 30, 2003ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, October 8, 2002ASSIGNED TO EXAMINER
Tuesday, August 27, 2002NON-FINAL ACTION E-MAILED
Wednesday, August 21, 2002ASSIGNED TO EXAMINER

Related Keywords

genemay reagents chemicals scientific research biological composite sale hazardous infectious manufacture